Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Momir Mikov

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|June 20, 2019
Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This DiseaseTanja Šarenac, Momir Mikov
Medicinski Pregled|July 28, 2011
[Counterfeit drugs as a gobal threat to health]Svetlana Golocorbin Kon, Momir Mikov
European Journal of Drug Metabolism and Pharmacokinetics|December 2, 2006
Chemistry, biosynthesis, analysis, chemical & metabolic transformations and pharmacologyMomir Mikov, J Paul Fawcett
Frontiers in Pharmacology|October 16, 2018
Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and NutrientsTanja M Šarenac, Momir Mikov
Journal of Receptor and Signal Transduction Research|June 21, 2013
The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disordersVanesa Stepanov, Karmen Stankov, Momir Mikov
Current Pharmaceutical Design|October 11, 2016
Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug ResponseNebojsa Pavlovic, Bojan Stanimirov, Momir Mikov
Biomedical Chromatography : BMC|October 16, 2016
Bile acids and their oxo derivatives: Potential inhibitors of carbonic anhydrase I and II, androgen receptor antagonists and CYP3A4 substratesJovana Trifunović, Vladan Borčić, Momir Mikov
Medicinski Pregled|October 21, 2003
[Current aspects in pharmacologic use of bile acids]Momir Mikov, Ksenija Kuhajda, Julijan Kandrac
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 21, 2012
The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseMaja Stojancevic, Karmen Stankov, Momir Mikov
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 7, 2015
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesBojan Stanimirov, Karmen Stankov, Momir Mikov
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|June 20, 2019
Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This DiseaseTanja Šarenac, Momir Mikov
Medicinski Pregled|July 28, 2011
[Counterfeit drugs as a gobal threat to health]Svetlana Golocorbin Kon, Momir Mikov
European Journal of Drug Metabolism and Pharmacokinetics|December 2, 2006
Chemistry, biosynthesis, analysis, chemical & metabolic transformations and pharmacologyMomir Mikov, J Paul Fawcett
Frontiers in Pharmacology|October 16, 2018
Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and NutrientsTanja M Šarenac, Momir Mikov
Journal of Receptor and Signal Transduction Research|June 21, 2013
The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disordersVanesa Stepanov, Karmen Stankov, Momir Mikov
Current Pharmaceutical Design|October 11, 2016
Bile Acids as Novel Pharmacological Agents: The Interplay Between Gene Polymorphisms, Epigenetic Factors and Drug ResponseNebojsa Pavlovic, Bojan Stanimirov, Momir Mikov
Biomedical Chromatography : BMC|October 16, 2016
Bile acids and their oxo derivatives: Potential inhibitors of carbonic anhydrase I and II, androgen receptor antagonists and CYP3A4 substratesJovana Trifunović, Vladan Borčić, Momir Mikov
Medicinski Pregled|October 21, 2003
[Current aspects in pharmacologic use of bile acids]Momir Mikov, Ksenija Kuhajda, Julijan Kandrac
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 21, 2012
The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseMaja Stojancevic, Karmen Stankov, Momir Mikov
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 7, 2015
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesBojan Stanimirov, Karmen Stankov, Momir Mikov
Pageof 19